APPOINTMENT, ASSIGNMENT AND ASSUMPTION AGREEMENTAppointment, Assignment and Assumption Agreement • November 15th, 2023 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • New York
THIS APPOINTMENT, ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”) is entered into and effective as of November 9, 2023 by and among EQRx, Inc., a Delaware corporation (the “Company”), Revolution Medicines, Inc. (“Parent”), Continental Stock Transfer & Trust Company, a New York corporation (“Continental”) and Equiniti Trust Company, LLC, a New York limited liability trust company (“Equiniti”).
